SOFLAX EX MICRO-ENEMA 2 MG
BISACODYL : 2 MG · DIN 02230400 · PHARMASCIENCE INC
Health Canada status: APPROVED
What is SOFLAX EX MICRO-ENEMA?
SOFLAX EX MICRO-ENEMA 2 MG contains BISACODYL : 2 MG. It is listed in the Health Canada Drug Product Database under DIN 02230400, held by PHARMASCIENCE INC, supplied as ENEMA ; SUSPENSION for RECTAL administration. Health Canada currently lists it as approved, status dated 18-Dec-1996. Nexara Health is a licensed Canadian wholesale distributor (DEL 3-002896-A) and can source this product for hospitals, pharmacies and clinics. Availability and lead time are confirmed per order.
Product details and regulatory record
| DIN | 02230400 |
|---|---|
| Brand name | SOFLAX EX MICRO-ENEMA |
| Generic / active ingredient | BISACODYL : 2 MG |
| Manufacturer | PHARMASCIENCE INC |
| Strength | 2 MG |
| Dosage form | ENEMA ; SUSPENSION |
| Route of administration | RECTAL |
| Schedule | Ethical |
| ATC code | A06AB02 BISACODYL |
| AHFS class | 28:16.08.32 |
| Biosimilar | No |
| Health Canada status | APPROVED |
| Status date | 18-Dec-1996 |
| Original market date | 1997-04-30 00:00:00 |
What can be used instead?
Other Canadian products sharing ATC code A06AB02 BISACODYL. 16 of 59 DINs in this group are currently marketed — marketed products are listed first, because that is what can actually be bought. These tables describe supply, not clinical equivalence: substitution rests with the prescriber or pharmacist, and interchangeability is determined provincially.
| Product | Strength | Form | Manufacturer | Health Canada status | DIN |
|---|---|---|---|---|---|
| AMB-BISACODYL | 10 MG | SUPPOSITORY | AMBICARE PHARMACEUTICALS INC. | MARKETED | DIN 02520478 |
| BISACODYL LAXATIVE | 5 MG | TABLET | JUNO OTC INC | MARKETED | DIN 02499126 |
| BISACODYL SUPPOSITORY | 10 MG | SUPPOSITORY | ANGITA PHARMA INC. | MARKETED | DIN 02489090 |
| BISACODYL SUPPOSITORY | 10 MG | SUPPOSITORY | JAMP PHARMA CORPORATION | MARKETED | DIN 02361450 |
| BISACODYL TABLETS | 5 MG | TABLET | SIGMA LIFE SCIENCES INC. | MARKETED | DIN 02417413 |
| BISACODYL TABLETS 5MG | 5 MG | TABLET | VITA HEALTH PRODUCTS INC | MARKETED | DIN 02243838 |
| BISACODYL TABLETS, 5 MG | 5 MG | TABLET | TIME-CAP LABORATORIES, INC | MARKETED | DIN 02550997 |
| BISACODYL-ODAN | 5 MG | TABLET (DELAYED-RELEASE) | ODAN LABORATORIES LTD | MARKETED | DIN 02273411 |
| CARTER'S LITTLE PILLS | 5 MG | TABLET | CHURCH & DWIGHT CANADA CORP | MARKETED | DIN 02219190 |
| CODULAX TABLETS | 5 MG | TABLET | SIGMA LIFE SCIENCES INC. | MARKETED | DIN 02238155 |
Who else supplies BISACODYL worldwide?
Nexara tracks national medicine registries and published price lists across multiple markets. BISACODYL appears in 54 registered pack listings across 7 markets, published on 5 different national price bases. Where a Canadian route is closed, that is where an alternative route of supply starts — subject to the import rules in both countries.
Registered listings are not stock. Ask us to confirm what can actually be sourced for your order.
How can I get it?
This product is approved by Health Canada but not yet marketed in Canada, so there is no Canadian supply to draw on today. Nexara can tell you whether it has been launched, and can look at supply from other markets where a Canadian pack is not required or where importation is permitted.
Ordering questions
Who can buy this from Nexara?
Licensed entities only. Nexara holds Health Canada establishment licence DEL 3-002896-A and ships only to a licensed address.
Is there a minimum order?
Yes, set per product line and per pack multiple rather than on the order total, so you are never asked to buy a part-pack. The minimum for this line is confirmed with your quote.
What is the lead time?
Confirmed per order at quotation, and it depends on current stock position and whether the product is in shortage.
Can Nexara supply this for a clinical trial?
Yes — comparator and background-therapy supply, including sourcing from other markets where a Canadian pack will not satisfy the protocol. Clinical trial supply.